China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) was the target of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 39,129 shares, a growth of 519.4% from the April 15th total of 6,317 shares. Based on an average trading volume of 522,436 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.2% of the company’s shares are short sold.
A hedge fund recently raised its stake in China Pharma stock. Renaissance Technologies LLC raised its holdings in shares of China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) by 55.7% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 778,938 shares of the company’s stock after buying an additional 278,500 shares during the period. Renaissance Technologies LLC owned about 1.79% of China Pharma worth $258,000 at the end of the most recent quarter.
Shares of NYSEAMERICAN CPHI traded up $0.01 during trading on Tuesday, hitting $0.30. 192,206 shares of the company traded hands, compared to its average volume of 741,076. China Pharma has a fifty-two week low of $0.19 and a fifty-two week high of $0.84.
China Pharma (NYSEAMERICAN:CPHI) last announced its quarterly earnings data on Wednesday, May 15th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $2.93 million for the quarter.
WARNING: This piece of content was reported by Highlight Press and is owned by of Highlight Press. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at https://highlightpress.com/2019/05/21/china-pharma-holdings-inc-cphi-short-interest-update.html.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules.
See Also: How Investors Use a Balance Sheet
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.